Abstract
This Health Policy Report reviews the history of the relationships between academic institutions and industrial organizations in the United States and discusses recent developments in this area. Academic–industrial relationships have fostered the development and dissemination of valuable medical advances, but they have also resulted in financial conflicts of interest that have threatened both the welfare of subjects enrolled in clinical research trials and the integrity of the research process. The author outlines strategies for managing academic–industrial relationships so as to safeguard both human subjects and the integrity of research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.